# Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus

> **NCT01377844** · PHASE2 · COMPLETED · sponsor: **Theracos** · enrollment: 288 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** EGT0001442
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01377844
- **Lead sponsor:** Theracos
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2021-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377844, "Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01377844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*